Therapeutic Solutions International Announces Engagement With PLS CPA’s
September 15, 2015 08:45 ET
OCEANSIDE, CA–(Marketwired – Sep 15, 2015) – Therapeutics Solutions International, Inc. (OTC PINK: TSOI) announced today the signing of an engagement with PLS CPA, A PC of San Diego CA. On September 10, 2015, Therapeutic Solutions International, Inc. (the “Company”), approved the engagement of PLS CPA’s (“PLS”) as the Company’s independent registered public accounting firm beginning with the fiscal year ended December 31, 2013. The engagement of PLS has been approved by the Board of Directors of the Company on September, 10 2015.
“We are very pleased to engage PLS CPA’s as our independent audit firm and look forward to working closely with them to bring our financial filing current,” said Tim Dixon, CEO of Therapeutic Solutions International, Inc.
About PLS CPA’s
We participate in peer reviews and continue our membership in professional societies, including the American Institute of Certified Public Accountants and The California Society of Certified Public Accountants. PLS CPA’s is a leader in the certified public accounting industry, providing clients with financial strategies for accomplishing their goals as well as competent, unbiased answers to their questions. Our financial advice is consistent with the highest standards of independence and appropriateness required by all disciplines in the accounting profession.
About Therapeutic Solutions International, Inc.
The Company’s corporate website is www.therapeuticsolutionsint.com. Our new products can be viewed on www.projuvenol.com and products can be ordered at www.youcanordernow.com.
These Supplement products have not been evaluated by the United States Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any diseases.
Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project” or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous risk factors as set forth in our SEC filings. To the extent that statements in this press release are not strictly historical, including statements as to product launch timing, revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future collaboration agreements, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.
- Therapeutic Solutions International, Inc.